hyperphosphorylated tau| What ishyperphosphorylated tau|Papers onhyperphosphorylated tau|Research Onhyperphosphorylated tau | Publications onhyperphos

1.

Hyperphosphorylated tau in young and middle-aged subjects.

Elobeid A, Soininen H, Alafuzoff I.

Acta Neuropathol. 2011 Dec 11. [Epub ahead of print]

PMID:

22160320

[PubMed - as supplied by publisher]

Related citations

2.

Enriched odor exposure decrease tau phosphorylation in the rat hippocampus and cortex.

Liao K, Zhu LQ.

Neurosci Lett. 2011 Dec 2. [Epub ahead of print]

PMID:

22155098

[PubMed - as supplied by publisher]

Related citations

3.

Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease.

Salminen A, Kaarniranta K, Haapasalo A, Hiltunen M, Soininen H, Alafuzoff I.

Prog Neurobiol. 2011 Nov 22. [Epub ahead of print]

PMID:

22138392

[PubMed - as supplied by publisher]

Related citations

4.

CEREBRAL Aβ(42) DEPOSITS AND MICROVASCULAR PATHOLOGY IN AGEING BABOONS.

Ndung'u M, Härtig W, Wegner F, Mwenda JM, Low RW, Akinyemi RO, Kalaria RN.

Neuropathol Appl Neurobiol. 2011 Nov 29. doi: 10.1111/j.1365-2990.2011.01246.x. [Epub ahead of print]

PMID:

22126319

[PubMed - as supplied by publisher]

Related citations

5.

Interaction between α-Synuclein and Other Proteins in Neurodegenerative Disorders.

Jellinger KA.

ScientificWorldJournal. 2011;11:1893-907. Epub 2011 Oct 24.

PMID:

22125446

[PubMed - in process]

Free PMC Article

Related citations

6.

(Val(8)) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains.

Li L, Zhang ZF, Holscher C, Gao C, Jiang YH, Liu YZ.

Eur J Pharmacol. 2011 Nov 12. [Epub ahead of print]

PMID:

22115895

[PubMed - as supplied by publisher]

Related citations

7.

The Interface between Cytoskeletal Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related Disorders.

Kang DE, Roh SE, Woo JA, Liu T, Bu JH, Jung AR, Lim Y.

Exp Neurobiol. 2011 Jun;20(2):67-80. Epub 2011 Jun 30.

PMID:

22110363

[PubMed]

Free PMC Article

Related citations

8.

Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B.

Ohmi K, Zhao HZ, Neufeld EF.

PLoS One. 2011;6(11):e27461. Epub 2011 Nov 9.

PMID:

22096577

[PubMed - in process]

Free PMC Article

Related citations

9.

Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1.

Platt B, Drever B, Koss D, Stoppelkamp S, Jyoti A, Plano A, Utan A, Merrick G, Ryan D, Melis V, Wan H, Mingarelli M, Porcu E, Scrocchi L, Welch A, Riedel G.

PLoS One. 2011;6(11):e27068. Epub 2011 Nov 11.

PMID:

22096518

[PubMed - in process]

Free PMC Article

Related citations

10.

Long-term consequences of repetitive brain trauma: chronic traumatic encephalopathy.

Stern RA, Riley DO, Daneshvar DH, Nowinski CJ, Cantu RC, McKee AC.

PM R. 2011 Oct;3(10 Suppl 2):S460-7.

PMID:

22035690

[PubMed - in process]

Related citations

11.

GSPE interferes with tau aggregation in vivo: implication for treating tauopathy.

Santa-Maria I, Diaz-Ruiz C, Ksiezak-Reding H, Chen A, Ho L, Wang J, Pasinetti GM.

Neurobiol Aging. 2011 Nov 3. [Epub ahead of print]

PMID:

22054871

[PubMed - as supplied by publisher]

Related citations

12.

Multi-target-directed ligands in Alzheimer's disease treatment.

Bajda M, Guzior N, Ignasik M, Malawska B.

Curr Med Chem. 2011 Nov 1;18(32):4949-75.

PMID:

22050745

[PubMed - in process]

Related citations

13.

Metabolic Reserve as a Determinant of Cognitive Aging.

Stranahan AM, Mattson MP.

J Alzheimers Dis. 2011 Nov 1. [Epub ahead of print]

PMID:

22045480

[PubMed - as supplied by publisher]

Related citations

14.

Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.

Wilhelmus MM, de Jager M, Rozemuller AJ, Brevé J, Bol JG, Eckert RL, Drukarch B.

J Pathol. 2012 Jan;226(1):132-42. doi: 10.1002/path.2984. Epub 2011 Oct 18.

PMID:

22009441

[PubMed - in process]

Related citations

15.

Phosphorylation of microtubule-associated protein tau by AMPK-related kinases.

Yoshida H, Goedert M.

J Neurochem. 2011 Oct 10. doi: 10.1111/j.1471-4159.2011.07523.x. [Epub ahead of print]

PMID:

21985311

[PubMed - as supplied by publisher]

Related citations

16.

Current and emerging drug treatment options for Alzheimer's disease: a systematic review.

Herrmann N, Chau SA, Kircanski I, Lanctôt KL.

Drugs. 2011 Oct 22;71(15):2031-65. doi: 10.2165/11595870-000000000-00000.

PMID:

21985169

[PubMed - in process]

Related citations

17.

Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy.

Carroll JC, Iba M, Bangasser DA, Valentino RJ, James MJ, Brunden KR, Lee VM, Trojanowski JQ.

J Neurosci. 2011 Oct 5;31(40):14436-49.

PMID:

21976528

[PubMed - indexed for MEDLINE]

Related citations

18.

Current and Emerging Drug Treatment Options for Alzheimer's Disease: A Systematic Review.

Herrmann N, Chau SA, Kircanski I, Lanctôt KL.

Drugs. 2011 Oct 4. [Epub ahead of print]

PMID:

21975572

[PubMed - as supplied by publisher]

Related citations

19.

Improvement of the Detection of Neurodegenerative Alzheimer's Disease through a Specific Surface Chemistry Applied onto the Inner Surface of the Titration Well.

Mille C, Debarnot D, Zorzi W, Moualij BE, Coudreuse A, Legeay G, Quadrio I, Perret-Liaudet A, Poncin-Epaillard F.

J Biomater Sci Polym Ed. 2011 Sep 28. [Epub ahead of print]

PMID:

21967846

[PubMed - as supplied by publisher]

Related citations

20.

NMNAT suppresses Tau-induced neurodegeneration by promoting clearance of hyperphosphorylated Tauoligomers in a Drosophila model of tauopathy.

Ali YO, Ruan K, Zhai RG.

Hum Mol Genet. 2011 Oct 13. [Epub ahead of print]

PMID:

21965302

[PubMed - as supplied by publisher]